Partner Societies Webinars

ASGO - ESGO  2nd Joint Webinar on The Role of Surgery in Recurrent Ovarian Cancer in the Era of Targeted Therap

In a collaborative effort, the Asian Society of Gynecologic Oncology (ASGO) and the European Society of Gynaecological Oncology (ESGO) have succesfully initiated their second joint webinar.

  • Anna Fagotti, Italy
    Predicting Complete Resection in Recurrent Ovarian Cancer Surgery
  • Isabelle Ray-Coquard, France
    How 1st Line Systematic Therapies and Relapse Timing Can Impact Our Medical Practice for Relapse Management?
  • Hyun-Woong Cho, South Korea
    Surgical Management in Recurrent Ovarian Cancer: A Review of Current Evidence and Future Research Directions
  • Tingyan Shi, China
    Impact of Prior Target Agents Including PARP Inhibitors on Surgery Outcomes: Insights from the SOC-1 Trial
  • Kittipat Charoenkwan, Thailand - moderator

 

SFCO - ESGO:  New FIGO classification of endometrial cancers

In partnership with European Society of Gynaecological Oncology (ESGO) and French Society of Surgical Oncology (SFCO), we presented a webinar named: New FIGO Classification of Endometrial Cancers. The discussion was led by moderators Alejandra Martinez (FRA) and Martin Koskas (FRA). Renowned specialists including Christina Fotopoulou (UK), Cyrus Chargari (FRA) and Xavier Matias-Guiu (Spain) offered their insights and took part in a dynamic conversation on essential topics:

  • Key histopathologic changes and update of the new FIGO classification by Xavier Matias Guiu, Spain
  • Tailoring surgical treatment based on FIGO 2023 classification by Christina Fotopoulou, UK
  • Tailoring adjuvant treatment based on new FIGO classification by Cyrus Chargari, France

 

 

ASGO - ESGO  1st Joint Webinar on Fertility Preservation in gyneacologic cancers

In a collaborative effort, the Asian Society of Gynecologic Oncology (ASGO) and the European Society of Gynaecological Oncology (ESGO) have succesfully initiated their first joint webinar on fertility preservation in gynecologic cancers.

With rising cases in younger populations, this topic is increasingly critical. Leading experts, including Alexandros Rodolakis Greece), Philippe Morice (France) and Frédéric Amant (Belgium) from ESGO, and Nao Suzuki (Japan), Masato Yoshihara (Japan), and Jung Ryeol Lee (South Korea) from ASGO, have shared their insights and engaged in lively discussions. Participants had the chance to learn about the latest advancements and ask questions during the Q&A session.

This collaboration aims to foster deeper cooperation and innovation in the field, providing a platform for valuable knowledge exchange.